Enhancing Radiotherapy Sensitivity in Prostate Cancer with Lentinan-Functionalized Selenium Nanoparticles: Mechanistic Insights and Therapeutic Potential

Enhancing Radiotherapy Sensitivity in Prostate Cancer with Lentinan-Functionalized Selenium Nanoparticles: Mechanistic Insights and Therapeutic Potential

Radiation therapy is a cornerstone of prostate cancer (PCa) treatment. However, its limited tumor sensitivity and severe side effects restrict its clinical utility. Lentinan-functionalized selenium nanoparticles (LET-SeNPs) have shown promise in enhancing radiotherapy sensitivity and exhibiting anti...

Full description

Bibliographic Details
Main Authors: Yani Zou, Helin Xu, Xiu Wu, Xuesong Liu, Jianfu Zhao
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Pharmaceutics
Subjects:
LET-SeNPs
prostate cancer
radiosensitization
ROS
apoptosis
Online Access:https://www.mdpi.com/1999-4923/16/9/1230

Internet

https://www.mdpi.com/1999-4923/16/9/1230

Similar Items